Compound ID | 3659
Synonym(s): REDX 05777 | REDX-05777
Class: DNA synthesis inhibitor
| Agent Type: | Synthetic; Small molecule; Direct acting; |
| Spectrum of activity: | Gram-positive, Gram-negative & Antimycobacterial |
| Mechanism of action: | DNA synthesis inhibitor. DNA gyrase inhibitor and topoisomerase IV inhibitor |
| Target Pathogen: | Broad spectrum activity with greater potency against Gram-positive bacteria |
| Description: | A novel bacterial topoisomerase inhibitor (NBTI) with tricyclic northern head group |
| Institute where first reported: | Redx Pharma, Alderley Park, Cheshire, United Kingdom |
| Year first mentioned: | 2016 |
| Development status: | Experimental |
| External links: | |
| Citation: | https://doi.org/10.1128/AAC.02100-16 |
| Patent: | WO 2016/024096 |